retatrutide trial dosing just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Trial Data Dosing Schedule :

No difference in stomach cancer, postmenopausal breast cancer or thyroid cancer risk was seen between the two groups

Never let yourself get extremely hungry either

Instead, follow the manufacturer's instructions regarding replacement

They are not a substitute for nutrition, resistance training, medical supervision, or long-term planning

We were quite excited by the findings, as this study was the first to demonstrate a physiological role of GLP-1 in appetite control and energy intake in humans

GLP-1RAs alleviate vascular aging under chronic stress via increasing adiponectin (APN) levels and inhibiting aortic MMP-9 and MMP-2 expression in ApoE -/- mice [96, 149]